Last reviewed · How we verify
NCT05942495
SFGT for Persistent Anxiety and Depression
NA trial testing short-term schema focused group therapy in Depressive Symptoms in 15 participants. Completed in 2 February 2025.
2 February 2025
Quick facts
| Lead sponsor | GGZ Noord-Holland-Noord |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 15 |
| Start date | 18 July 2023 |
| Primary completion | 2 February 2025 |
| Estimated completion | 2 February 2025 |
| Sites | 1 location across Netherlands |
Drugs / interventions tested
- short-term schema focused group therapy
Conditions studied
- Depressive Symptoms — all drugs for Depressive Symptoms →
- Anxiety Disorders — all drugs for Anxiety Disorders →
- Persistent — all drugs for Persistent →
- Anxiety Depression — all drugs for Anxiety Depression →
Sponsor
GGZ Noord-Holland-Noord
Who can join
Adults 18 to 65, any sex, with Depressive Symptoms or Anxiety Disorders. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Rationale: Although there are effective treatments available for anxiety and depression, there is a large group of clients that does not benefit sufficiently from first-choice treatment. For this group of clients, no suitable alternative exists yet. One of the main hypothesis about maintaining factors is that there are underlying personality features that impede recovery. Schema focused therapy (SFT) is a transdiagnostic therapy focusing on underlying personality features. It has been proven to be an effective therapy for people with personality disorders and there are initial indications that SFT is also an effective treatment for anxiety and depressive symptoms. A short-term schema focused group therapy (SFGT) has been developed within GGZ-NHN, which is expected to benefit clients with persistent anxiety and depressive symptoms, but has not yet been studied. Objective of the study: In the present study the effectiveness of short-term SFGT (protocol of De Jager, Burger \& Groot) on (1) persistent anxiety and depressive symptoms, and (2) early maladaptive schemas (EMS), experiential avoidance and the mode of the healthy adult will be investigated.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05942495
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Depressive Symptoms
Currently open trials in the same condition.
- NCT07299903 — IMB-Based Sleep Hygiene Education for Menopausal Women: Effects on Sleep Quality and Depression · NA · recruiting
- NCT07413692 — BTL-699-2 and HPM-6000UF Devices for the Improvement of Depressive Symptoms and Urinary Incontinence in Postpartum and E · NA · recruiting
- NCT07413705 — BTL-699-2 and HPM-6000UF Devices for the Improvement of Depressive Symptoms and Sexual Function Among Perimenopausal and · NA · recruiting
- NCT07241325 — Psychological Well-Being, Depression, and Health-Related Quality of Life in Adults With Type 2 Diabetes: A Cross-Section · recruiting
- NCT07216326 — Our Voices Matter: Intervention for Depression in Youth · NA · recruiting
Other GGZ Noord-Holland-Noord trials
Trials by the same sponsor.
- NCT06749041 — Nor)Clozapine Kinetics and Side Effects in Therapy Resistant Schizophrenia and the Optimal Sampling Time for Therapeutic · not yet recruiting
- NCT06617663 — Online Therapy Youth, Equivalent to Treatment As Usual? · NA · recruiting
- NCT06101810 — The Efficacy of Treatments to Improve Self-esteem · NA · recruiting
- NCT05726812 — Plan My Life Together; a Group Training for Adolescents With ADHD · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05942495 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by GGZ Noord-Holland-Noord
- Last refreshed: 12 March 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05942495.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing